We are live on ! Find out more
TGV

TRV GP V Portfolio holdings

AUM $401M
1-Year Est. Return 284.76%
This Fund
S&P 500
This Quarter Est. Return
-5.38%
1 Year Est. Return
+284.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$401M
AUM Growth
-$28.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPP
1
Rapport Therapeutics
RAPP
$2.01B
$223M 55.68%
7,135,233
SEPN
2
Septerna Inc
SEPN
$1.51B
$149M 37.25%
6,215,591
MAZE
3
Maze Therapeutics
MAZE
$1.59B
$28.4M 7.08%
950,800

Similar funds

TRV GP V's Q1 2026 Portfolio in Review

As of Q1 2026, TRV GP V held 3 positions worth $401M, down 6.6% from $429M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0%. TRV GP V opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP V's ten largest holdings make up 100% of its $401M portfolio in Q1 2026.
  • TRV GP V opened 0 new positions and closed 0 in Q1 2026.
  • TRV GP V's portfolio value fell 6.6% quarter-over-quarter to $401M.

Based on TRV GP V's 13F filing for Q1 2026, filed 7 May 2026.